Retinoblastoma in Asia.
Journal
Eye (London, England)
ISSN: 1476-5454
Titre abrégé: Eye (Lond)
Pays: England
ID NLM: 8703986
Informations de publication
Date de publication:
01 2019
01 2019
Historique:
received:
18
09
2018
accepted:
04
10
2018
revised:
23
09
2018
pubmed:
6
11
2018
medline:
18
5
2019
entrez:
3
11
2018
Statut:
ppublish
Résumé
Asia-Pacific region bears a significant global burden of retinoblastoma (RB), therefore understanding RB in Asia-Pacific region is important. Based on the year 2013 population estimates, 43% (3452 of 8099 children) of the global burden of RB lives in 6 countries of Asia-Pacific region: 1486 children in India, 1103 children in China, 277 children in Indonesia, 260 children in Pakistan, 184 children in Bangladesh, 142 children in Philippines. There exists a wide disparity, technological and socio-economical, within countries in this region resulting in a varied pattern of clinical presentation and survival varies. Challenges in developing nations are not just technological, but also social. Opportunities emerge for research to study and understand the socio-economical aspects of the disease to develop interventions that are relevant culturally and feasible economically. Possible steps include disease education and counselling, universal screening, highly subsidized/free of cost treatment for low socioeconomic strata, raising funds through the government and non-governmental organizations, sensitization and training of man-power in screening, diagnosis and treatment, and developing new specialized centers with tele-ophthalmology services. 摘要: 亚太地区是全球主要的视网膜母细胞瘤 (RB) 患病地区, 因此了解亚太地区RB的患病情况具有重要意义。根据2013年人口估计, 全球患RB儿童中的43%(8099名儿童中的3452名)生活在亚太地区的6个国家:印度1486名儿童、中国1103名儿童、印度尼西亚277名儿童、巴基斯坦260名儿童、孟加拉国184名儿童、菲律宾142名儿童。各国在技术和社会经济方面存在着巨大差异, 导致了临床表现和生存数量的不同。发展中国家面临的挑战不仅是技术方面的, 还有社会方面的。学习理解该疾病的社会经济方面的特点以制定与文化相关和经济可行性的干预措施很重要。可能采取的措施包括疾病的教育咨询、普遍筛查、对社会经济地位低的人群给予高补贴/免费治疗、通过政府和非政府组织筹集资金、提高筛查及诊断和治疗方面的人才的认识和培训, 以及发展具有远程眼科服务的新型专业中心。.
Autres résumés
Type: Publisher
(chi)
摘要: 亚太地区是全球主要的视网膜母细胞瘤 (RB) 患病地区, 因此了解亚太地区RB的患病情况具有重要意义。根据2013年人口估计, 全球患RB儿童中的43%(8099名儿童中的3452名)生活在亚太地区的6个国家:印度1486名儿童、中国1103名儿童、印度尼西亚277名儿童、巴基斯坦260名儿童、孟加拉国184名儿童、菲律宾142名儿童。各国在技术和社会经济方面存在着巨大差异, 导致了临床表现和生存数量的不同。发展中国家面临的挑战不仅是技术方面的, 还有社会方面的。学习理解该疾病的社会经济方面的特点以制定与文化相关和经济可行性的干预措施很重要。可能采取的措施包括疾病的教育咨询、普遍筛查、对社会经济地位低的人群给予高补贴/免费治疗、通过政府和非政府组织筹集资金、提高筛查及诊断和治疗方面的人才的认识和培训, 以及发展具有远程眼科服务的新型专业中心。.
Identifiants
pubmed: 30385881
doi: 10.1038/s41433-018-0244-7
pii: 10.1038/s41433-018-0244-7
pmc: PMC6328585
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
87-96Références
Kivelä T. The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 2009;93:1129–31.
Dimaras H, Kimani K, Dimba EA, Gronsdahl P, White A, Chan HS, et al. Retinoblastoma. Lancet. 2012;379:1436–46.
Kivelä T. 200 years of success initiated by James Wardrop’s 1809 monograph on retinoblastoma. Actaophthalmologica. 2009;8:810–2.
Abramson DH. Retinoblastoma in the 20th century: past success and future challenges the Weisenfeld lecture. Invest Ophthalmol & Vis Sci. 2005;46:2684–91.
Abramson DH, Beaverson K, Sangani P, Vora RA, Lee TC, Hochberg HM, et al. Screening for retinoblastoma: presenting signs as prognosticators of patient and ocular survival. Pediatrics. 2003;112:1248–55.
pubmed: 14654593
Dimaras H, Corson TW, Cobrinik D, White A, Zhao J, Munier FL, et al. Retinoblastoma. Nat Rev Dis Prim. 2015;1:15021.
pubmed: 27189421
Rodriguez-Galindo C, Wilson MW, Chantada G, Fu L, Qaddoumi I, Antoneli C, et al. Retinoblastoma: one world, one vision. Pediatrics. 2008;122:e763–70.
pubmed: 18762512
pmcid: 2844325
Broaddus E, Topham A, Singh AD. Survival with retinoblastoma in the USA: 1975–2004. Br J Ophthalmol. 2009;93:24–7.
pubmed: 18718969
MacCarthy A, Birch JM, Draper GJ, Hungerford JL, Kingston JE, Kroll ME, et al. Retinoblastoma: treatment and survival in Great Britain 1963 to 2002. Br J Ophthalmol. 2009;93:38–9.
pubmed: 18838414
MacCarthy A, Draper GJ, Steliarova-Foucher E, Kingston JE. Retinoblastoma incidence and survival in European children (1978–1997). Report from the Automated Childhood Cancer Information System project. Eur J Cancer. 2006;42:2092–102.
pubmed: 16919773
Kao LY, Su WW, Lin YW. Retinoblastoma in Taiwan: survival and clinical characteristics 1978–2000. Jpn J Ophthalmol. 2002;46:577–80.
pubmed: 12457919
EN Gichigo, Kariuki-Wanyoike, Kimani MM, Nentwich K, Retinoblastoma MM. in Kenya: survival and prognostic factors. Ophthalmologe. 2015;112:255–60.
Goolam S, Kana H, Welsh N, Wainwright L, Poole J, Mayet I. A 20-Year Retrospective Review of Retinoblastoma at Two Tertiary Academic Hospitals in Johannesburg, South Africa. Ocul Oncol Pathol. 2018;4:170–5.
pubmed: 29765949
Prasad Sah K, Saiju R, Roy P, Kafle S Retinoblastoma: ten years experience at Kanti Children’s Hospital. Journal of the Nepal Medical Association. 2013;52:576–9.
Canturk S, Qaddoumi I, Khetan V, Ma Z, Furmanchuk A, Antoneli CB, et al. Survival of retinoblastoma in less-developed countries impact of socioeconomic and health-related indicators. Br J Ophthalmol. 2010;94:1432–6.
pubmed: 20733021
Chawla B, Kumar K, Singh AD. Influence of socioeconomic and cultural factors on retinoblastoma management. Asia Pac J Oncol Nurs. 2017;4:187.
pubmed: 28695163
pmcid: 5473088
Usmanov RH, Kivelä T. Predicted trends in the incidence of retinoblastoma in the Asia-Pacific region. Asia-Pac J Ophthalmol. 2014;3:151–7.
Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015;100:172–8.
pubmed: 26061162
Kaliki, S., Patel, A., Iram, S., Ramappa, G., Mohamed, A., & Palkonda, V. A. R. (2017). RETINOBLASTOMA IN INDIA. Retina, 1. https://doi.org/10.1097/iae.0000000000001962
pubmed: 29210937
Singh U, Katoch D, Kaur S, Dogra MR, Bansal D, Kapoor R. Retinoblastoma: a sixteen-year review of the presentation, treatment, and outcome from a tertiary care institute in Northern India. Ocul Oncol Pathol. 2018;4:23–32.
Shah PK, Narendran V, Kalpana N. Outcomes of intra-and extraocular retinoblastomas from a single institute in South India. Ophthalmic Genet. 2015;36:248–50.
pubmed: 24372404
Kaliki S, Shields CL, Eagle JR, Iram S, Shields JA. High-risk intraocular retinoblastoma: comparison between Asian Indians and Americans from two major referral centers. Retina. 2017;38:2023–9.
pubmed: 28834944
Kaliki S, Patel A, Iram S, Palkonda VA. Clinical presentation and outcomes of stage III or stage IV retinoblastoma in 80 Asian Indian patients. J Pediatr Ophthalmol Strabismus. 2017;54:177–84.
pubmed: 27977038
Kiratli PÖ, Kiratli H, Ercan MT. Visualization of orbital retinoblastoma with technetium-99m (V) dimercaptosuccinic acid. Ann Nucl Med. 1998;12:157–9.
pubmed: 9673718
Moll AC, Hoekstra OS, Imhof SM, Comans EF, Meeteren AS, van der Valk P, et al. Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalmic Genet. 2004;25:31–5.
pubmed: 15255112
Chantada G, Fandiño A, Casak S, Manzitti J, Raslawski E, Schvartzman E. Treatment of overt extraocular retinoblastoma. Med Pediatr Oncol. 2003;40:158–61.
pubmed: 12518344
Chantada GL, Guitter MR, Fandiño AC, Raslawski EC, de Davila MT, Vaiani E, et al. Treatment results in patients with retinoblastoma and invasion to the cut end of the optic nerve. Pediatr Blood Cancer. 2009;52:218–22.
pubmed: 18937327
Honavar SG, Manjandavida FP, Reddy VA. Orbital retinoblastoma: An update. Indian J Ophthalmol. 2017;65:435.
pubmed: 28643706
pmcid: 5508452
Ali MJ, Honavar SG, Reddy VA. Orbital retinoblastoma: Present status and future challenges–A review. Saudi J Ophthalmol. 2011;25:159–67.
pubmed: 23960917
Chawla B, Hasan F, Seth R, Pathy S, Pattebahadur R, Sharma S, et al. Multimodal therapy for stage III retinoblastoma (International Retinoblastoma Staging System): A prospective comparative study. Ophthalmology. 2016;123:1933–9.
pubmed: 27449712
Wiangnon S, Veerakul G, Nuchprayoon I, et al. Childhood cancer incidence and survival 2003-2005, Thailand: study from the Thai Pediatric Oncology Group. Asian Pac J Cancer Prev. 2011;12:2215–20.
pubmed: 22296359
Wongmas P, Jetsrisuparb A, Komvilaisak P, et al. Incidences, trends and long term outcomes of retinoblastoma in three cancer registries, Thailand. Asian Pac J Cancer Prev. 2015;16:6899–902.
pubmed: 26514464
Atchaneeyasakul LO, Wongsiwaroj C, Uiprasertkul M, Sanpakit K, Thephamongkhol K, Trinavarat A. Prognostic factors and treatment outcomes of retinoblastoma in pediatric patients: a single-institution study. Jpn J Ophthalmol. 2009;53:35–9.
pubmed: 19184307
Aung L, Chan YH, Yeoh EJ, Tan PL, Quah TC. Retinoblastoma: a recent experience at the National University Hospital, Singapore. Ann Acad Med Singap. 2009;38:693–8.
pubmed: 19736573
Chantada G, Doz F, Antoneli CBG, et al. A proposal for an International retinoblastoma staging system. Pediatr Blood Cancer. 2006;47:801–5.
pubmed: 16358310
Jeyabal P, Sundar G. Anophthalmic sockets in retinoblastoma: a single center experience. Asia Pac J Ophthalmol. 2018. https://doi.org/10.22608/APO.201892.
Knudson AG. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci. 1971;68:820–3.
pubmed: 5279523
Leander C, Fu LC, Pena A, Howard SC, Rodriguez‐Galindo C, Wilimas JA, et al. Impact of an education program on late diagnosis of retinoblastoma in Honduras. Pediatr Blood Cancer. 2007;49:817–9.
pubmed: 17009236
Borooah VK. Gender bias among children in India in their diet and immunisation against disease. Soc Sci Med. 2004;58:1719–31.
pubmed: 14990373
Pillay-van Wyk V, Bradshaw D. Mortality and socioeconomic status: the vicious cycle between poverty and ill health. Lancet Glob Health. 2017;5:e851–2.
pubmed: 28807172
Ellsworth RM. Orbital retinoblastoma. Trans Am Ophthalmol Soc. 1974;72:79.
pubmed: 4462255
pmcid: 1311388
Grabowski EF, Abramson DH. Intraocular and extraocular retinoblastoma. Hematology/Oncology. Clinics. 1987;1:721–35.
Badhu B, Sah SP, Thakur SK, Dulal S, Kumar S, Sood A, et al. Clinical presentation of retinoblastoma in Eastern Nepal. Clin Exp Ophthalmol. 2005;33:386–9.
pubmed: 16033351
Gündüz K, Müftüoglu O, Günalp I, Ünal E, Taçyıldız N. Metastatic retinoblastoma: clinical features, treatment, and prognosis. Ophthalmology. 2006;113:1558–66.
pubmed: 16828510
Chawla B, Hasan F, Azad R, Seth R, Upadhyay AD, Pathy S, et al. Clinical presentation and survival of retinoblastoma in Indian children. Br J Ophthalmol. 2015;100:172–6.
pubmed: 26061162
Biswas J, Das D, Krishnakumar S, Shanmugam MP. Histopathologic analysis of 232 eyes with retinoblastoma conducted in an Indian tertiary-care ophthalmic center. J Pediatr Ophthalmol Strabismus. 2003;40:265.
pubmed: 14560832
Elzomor H, Taha H, Nour R, Aleieldin A, Zaghloul MS, Qaddoumi I, et al. A multidisciplinary approach to improving the care and outcomes of patients with retinoblastoma at a pediatric cancer hospital in Egypt. Ophthalmic Genet. 2017;38:345–51.
pubmed: 28085527
Sitorus RS, Moll AC, Suhardjono S, Simangunsong LS, Riono P, Imhof S, et al. The effect of therapy refusal against medical advice in retinoblastoma patients in a setting where treatment delays are common. Ophthalmic Genet. 2009;30:31–6.
pubmed: 19172508
Olteanu C, Dimaras H. Enucleation refusal for retinoblastoma: a global study. Ophthalmic Genet. 2016;37:137–43.
pubmed: 25078476
Austoker J, Bankhead C, Forbes LJ, Atkins L, Martin F, Robb K, et al. Interventions to promote cancer awareness and early presentation: systematic review. Br J Cancer. 2009;101(S2):31.